Add like
Add dislike
Add to saved papers

Psychometric analysis of the pediatric quality of life inventory 3.0 neuromuscular module administered to patients with duchenne muscular dystrophy: A rasch analysis.

Muscle & Nerve 2018 September
INTRODUCTION: Our objective in this study was to assess the psychometric properties of the English (UK and USA) version of the Pediatric Quality of Life Inventory 3.0 Neuromuscular Module (PedsQL NMM) administered to patients with Duchenne muscular dystrophy (DMD).

METHODS: Patients with DMD from the UK and the US completed the PedsQL NMM online. The psychometric properties of the instrument were examined using Rasch analysis.

RESULTS: A total of 278 patients completed the PedsQL NMM. Model misfit was identified for 6 of 25 items (item fit residual: mean 0.162, standard deviation [SD] 2.333), 22 of 25 items displayed disordered thresholds, and item dependency was high. The mean person fit residual was estimated at -0.183 (SD 1.475). The Person Separation Index and Cronbach's α were estimated at 0.904 and 0.915, respectively.

DISCUSSION: The English version of the PedsQL NMM may not be a valid measure of health-related quality of life in patients with DMD. Muscle Nerve 58: 367-373, 2018.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app